ERBB2 and breast neoplasm: To further investigate the correspondence between our personalized integrative HLA typing approach, HLA expression quantification in tumor vs. normal, and the subsequent impact on the immunobiology of tumors, we applied our integrative approach on five ER + /HER2- primary breast tumors with matched histologically normal adjacent breast tissue.